Protek | Income Statement

Fiscal year is January-December. All values RUB Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
139,311
156,948
195,309
241,482
258,455
251,733
Cost of Goods Sold (COGS) incl. D&A
122,563
3,581
2,762
3,179
3,914
3,486
Gross Income
16,748
18,697
25,990
28,513
30,159
32,737
SG&A Expense
13,281
372
271
279
367
387
EBIT
-
105
143
143
145
130
Unusual Expense
1,045
3
27
-
3
-
Non Operating Income/Expense
400
1,524
2,995
1,877
359
702
Interest Expense
19
1
5
7
16
18
Pretax Income
2,644
5,812
13,742
7,887
7,663
8,046
Income Tax
626
1,019
2,772
1,774
1,787
1,666
Equity in Affiliates
-
-
-
-
5
-
Consolidated Net Income
2,018
4,793
10,970
6,113
5,880
6,380
Net Income
1,962
122
177
88
97
98
Net Income After Extraordinaries
1,962
122
177
88
97
98
Net Income Available to Common
1,962
122
177
88
97
98
EPS (Basic)
3.73
9.16
21.75
11.53
10.71
11.73
Basic Shares Outstanding
526
516
499
514
527
527
EPS (Diluted)
3.73
9.16
21.75
11.53
10.71
11.73
Diluted Shares Outstanding
526
516
499
514
527
527
EBITDA
3,985
127
158
159
171
158
Other Operating Expense
349
285
575
223
270
257
Non-Operating Interest Income
189
154
605
630
321
334
Minority Interest Expense
56
71
117
191
234
196

About Protek

View Profile
Address
2, ulica Chermyanskaya
Moscow MC 127282
Russian Federation
Employees -
Website http://www.protek-group.ru
Updated 07/08/2019
Protek PJSC distributes, manufactures and sales of pharmaceuticals, health and beauty care products. It operates through the following segments: Production, Distribution and Retail. The company was founded on November 21, 1990 and is headquartered in Moscow, Russia.